BMRC sets new conditions for human trials of Bangavax vaccine bdnews24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bdnews24.com Daily Mail and Mail on Sunday newspapers.
Obaidur Masum, Senior Correspondent,
bdnews24.com
Published: 06 May 2021 11:42 AM BdST
Updated: 06 May 2021 11:51 AM BdST
Globe Biotech, a Bangladeshi company, applied for permission to begin clinical trials of its COVID-19 vaccine candidate ‘Bangavax’ in January. But, over three months later, it has yet to receive the approval of the Bangladesh Medical Research Council. );
}
As trials have yet to begin, it means the effectiveness of the domestically produced vaccine is still unknown.
Globe Biotech applied for approval to begin testing on humans, known as a clinical trial, on Jan 17.
According to the rules, applications are first screened by the BMRC’s National Research Ethics Committee. If the BMRC gives its ethical consent, it goes to the Directorate General of Drug Administration. There it will wait for the consideration and approval of the National Clinical Trial Advisory Committee.